These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 9730885

  • 1. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW, Witte ON.
    J Exp Med; 1998 Sep 07; 188(5):833-44. PubMed ID: 9730885
    [Abstract] [Full Text] [Related]

  • 2. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR, Halcomb KE, Contreras CM, Lowell CA, Witte ON, Satterthwaite AB.
    J Immunol; 2003 Aug 15; 171(4):1850-8. PubMed ID: 12902486
    [Abstract] [Full Text] [Related]

  • 3. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
    Kawakami Y, Kitaura J, Satterthwaite AB, Kato RM, Asai K, Hartman SE, Maeda-Yamamoto M, Lowell CA, Rawlings DJ, Witte ON, Kawakami T.
    J Immunol; 2000 Aug 01; 165(3):1210-9. PubMed ID: 10903718
    [Abstract] [Full Text] [Related]

  • 4. Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.
    Middendorp S, Dingjan GM, Maas A, Dahlenborg K, Hendriks RW.
    J Immunol; 2003 Dec 01; 171(11):5988-96. PubMed ID: 14634110
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM, Cambier JC.
    J Immunol; 1999 Apr 15; 162(8):4438-46. PubMed ID: 10201980
    [Abstract] [Full Text] [Related]

  • 6. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
    Takeshita H, Taniuchi I, Kato J, Watanabe T.
    Int Immunol; 1998 Apr 15; 10(4):435-44. PubMed ID: 9620599
    [Abstract] [Full Text] [Related]

  • 7. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
    Khan WN.
    Immunol Res; 2001 Apr 15; 23(2-3):147-56. PubMed ID: 11444380
    [Abstract] [Full Text] [Related]

  • 8. A kinase-dead allele of Lyn attenuates autoimmune disease normally associated with Lyn deficiency.
    Verhagen AM, Wallace ME, Goradia A, Jones SA, Croom HA, Metcalf D, Collinge JE, Maxwell MJ, Hibbs ML, Alexander WS, Hilton DJ, Kile BT, Starr R.
    J Immunol; 2009 Feb 15; 182(4):2020-9. PubMed ID: 19201855
    [Abstract] [Full Text] [Related]

  • 9. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt.
    Craxton A, Jiang A, Kurosaki T, Clark EA.
    J Biol Chem; 1999 Oct 22; 274(43):30644-50. PubMed ID: 10521450
    [Abstract] [Full Text] [Related]

  • 10. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T, Rothstein TL.
    J Immunol; 2003 Mar 15; 170(6):2806-10. PubMed ID: 12626529
    [Abstract] [Full Text] [Related]

  • 11. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
    Shinners NP, Carlesso G, Castro I, Hoek KL, Corn RA, Woodland RT, Scott ML, Wang D, Khan WN.
    J Immunol; 2007 Sep 15; 179(6):3872-80. PubMed ID: 17785824
    [Abstract] [Full Text] [Related]

  • 12. A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.
    Satterthwaite AB, Willis F, Kanchanastit P, Fruman D, Cantley LC, Helgason CD, Humphries RK, Lowell CA, Simon M, Leitges M, Tarakhovsky A, Tedder TF, Lesche R, Wu H, Witte ON.
    Proc Natl Acad Sci U S A; 2000 Jun 06; 97(12):6687-92. PubMed ID: 10829070
    [Abstract] [Full Text] [Related]

  • 13. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M, Poe JC, Satterthwaite AB, Wahl MI, Witte ON, Tedder TF.
    J Immunol; 2002 Jun 01; 168(11):5465-76. PubMed ID: 12023340
    [Abstract] [Full Text] [Related]

  • 14. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.
    Schubart DB, Rolink A, Schubart K, Matthias P.
    J Immunol; 2000 Jan 01; 164(1):18-22. PubMed ID: 10604987
    [Abstract] [Full Text] [Related]

  • 15. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
    Middendorp S, Hendriks RW.
    J Immunol; 2004 Feb 01; 172(3):1371-9. PubMed ID: 14734712
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
    Wahl MI, Fluckiger AC, Kato RM, Park H, Witte ON, Rawlings DJ.
    Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11526-33. PubMed ID: 9326643
    [Abstract] [Full Text] [Related]

  • 17. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40.
    Khan WN, Nilsson A, Mizoguchi E, Castigli E, Forsell J, Bhan AK, Geha R, Sideras P, Alt FW.
    Int Immunol; 1997 Mar 14; 9(3):395-405. PubMed ID: 9088978
    [Abstract] [Full Text] [Related]

  • 18. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking.
    Oda A, Ikeda Y, Ochs HD, Druker BJ, Ozaki K, Handa M, Ariga T, Sakiyama Y, Witte ON, Wahl MI.
    Blood; 2000 Mar 01; 95(5):1663-70. PubMed ID: 10688822
    [Abstract] [Full Text] [Related]

  • 19. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF.
    J Immunol; 1999 Jun 15; 162(12):7088-94. PubMed ID: 10358152
    [Abstract] [Full Text] [Related]

  • 20. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
    Wu HJ, Venkataraman C, Estus S, Dong C, Davis RJ, Flavell RA, Bondada S.
    J Immunol; 2001 Aug 01; 167(3):1263-73. PubMed ID: 11466342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.